[1]李珂,项奕.miRNA-19对葡萄膜黑色素瘤细胞增殖、凋亡、迁移和侵袭的影响及其机制研究[J].眼科新进展,2021,41(5):413-416.[doi:10.13389/j.cnki.rao.2021.0086]
　LI Ke,XIANG Yi.Effects of miRNA-19 on proliferation, apoptosis, migration and invasion of uveal melanoma cells and its mechanisms[J].Recent Advances in Ophthalmology,2021,41(5):413-416.[doi:10.13389/j.cnki.rao.2021.0086]
点击复制

miRNA-19对葡萄膜黑色素瘤细胞增殖、凋亡、迁移和侵袭的影响及其机制研究/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年5期
页码:
413-416
栏目:
实验研究
出版日期:
2021-05-05

文章信息/Info

Title:
Effects of miRNA-19 on proliferation, apoptosis, migration and invasion of uveal melanoma cells and its mechanisms
作者:
李珂; 项奕
430014　湖北省武汉市，华中科技大学同济医学院附属武汉中心医院眼科
Author(s):
LI Ke; XIANG Yi
Department of Ophthalmology,Wuhan Central Hospital,Tongji Medical College,Huazhong University of Science and Technology，Wuhan 430014,Hubei Province,China
关键词:
葡萄膜黑色素瘤; 增殖; 凋亡; 迁移; 侵袭
Keywords:
uveal melanoma;  proliferation;  apoptosis;  migration;  invasion
分类号:
R 774.1
DOI:
10.13389/j.cnki.rao.2021.0086
文献标志码:
A
摘要:
目的　探讨miR-19在葡萄膜黑色素瘤（UM）细胞中的表达及其对UM细胞增殖、凋亡、迁移和侵袭的影响及其作用机制。方法　qRT-PCR检测正常视网膜上皮细胞系ARPE-19和UM细胞系SP6.5、M23 中miR-19 的表达。将M23细胞分为miR-19 inhibitor组（转染miR-19-inhibitor）及miR-19 NC组(转染scramble）,MTT法检测各组细胞增殖，流式细胞术检测细胞凋亡，细胞划痕实验检测细胞迁移能力，Transwell实验检测细胞侵袭能力，Western blot检测表皮生长因子受体(EGFR)/丝氨酸-苏氨酸激酶（AKT）/哺乳动物雷帕霉素靶蛋白(mTOR)信号通路蛋白表达。结果　正常视网膜上皮细胞系ARPE-19中miR-19 相对表达量为1.35±0.13，均显著低于UM细胞系SP6.5与M23中miR-19相对表达量8.35±0.73和9.35±0.43(均为P<0.01) 。 M23 细胞转染后，miR-19 inhibitor组中miR-19表达量低于miR-19 NC组 (1.05±0.33 vs 8.05±0.64,P<0.01)。MTT法检测结果显示，转染24 h，miR-19 inhibitor组与miR-19 NC组光密度值比较，差异无统计学意义（P>0.05)；转染48 h、72 h、96 h，miR-19 inhibitor组光密度值均低于miR-19 NC组（均为P<0.05)。miR-19 inhibitor组细胞凋亡率高于miR-19 NC组［(15.34±2.35)% vs (8.23±0.72) %,P<0.05］。miR-19 inhibitor组细胞划痕愈合率低于miR-19 NC组 ［(23.7±2.1） % vs （68.9±5.1）%,P<0.05］。miR-19 inhibitor组侵袭细胞数少于miR-19 NC组［(45.1±3.9）个 vs （115.3±8.9）个,P<0.05］。miR-19 inhibitor组UM细胞系M23 EGFR蛋白表达量低于miR-19 NC组（0.43±0.03 vs 1.02±0.02,P<0.05) 。miR-19 inhibitor组AKT蛋白表达量低于miR-19 NC组（0.52±0.04 vs 1.12±0.05，P<0.05)。miR-19 inhibitor组mTOR蛋白表达量低于miR-19 NC组（0.63±0.05 vs 1.41±0.06，P<0.05）。结论　敲低miR-19 表达可抑制UM细胞增殖、迁移和侵袭能力并促进凋亡，其机制可能与EGFR/AKT/mTOR信号通路被抑制有关。
Abstract:
Objective　To investigate the expression of miR-19 in uveal melanoma (UM) and its effects on cell proliferation, apoptosis, migration and invasion and its mechanisms.Methods　Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect the expression of miR-19 in normal retinal pigment epithelial cell lines ARPE-19 and UM cell lines SP6.5 and M23. The M23 cell line was divided into miR-19 inhibitor group, in which the cells were transfected with miR-19 inhibitor, and miR-19 NC group, in which the cells were transfected with scramble. MTT assay was used to measure cell proliferation. Flow cytometry was used to measure apoptosis. Cell scratch test was used to measure cell migration ability. Transwell assay was used to measure cell invasion. Western blot was used to measure the expression of epithelial growth factor receptor (EGFR)/serine/threonineproteinkinase(AKT) /mammalian target of rapamycin (mTOR) signaling pathway protein.Results　The expression level of miR-19 in normal uveal epithelial cell line ARPE-19 was 1.35±0.13, and 8.35±0.73 and 9.35±0.43 in uveal melanoma cell lines SP6.5 and M23, respectively. The expression level of miR-19 in SP6.5 and M23 was significantly higher than that in ARPE-19 (both P<0.01). After transfection, the expression level of miR-19 in M23 cells of the miR-19 inhibitor group was lower than that in miR-19 NC group (1.05±0.33 vs 8.05±0.64, P<0.01). The results of MTT showed that after 24 hours of transfection, the optical density value was not statistically difference between miR-19 inhibitor group and miR-19 NC group (P>0.05). After transfection for 48 hours, 72 hours, 96 hours, the optical density value of miR-19 inhibitor group was significantly lower than miR-19 NC group (all P<0.05). The apoptosis rate of miR-19 inhibitor group was higher than that of miR-19 NC group ［(15.34±2.35)% vs (8.23±0.72)%, P<0.05］. The scratch healing rate in the miR-19 inhibitor group was lower than that in the miR-19 NC group ［(23.7±2.1)% vs (68.9±5.1)%, P<0.05］. The number of invasive cells in the miR-19 inhibitor group was less than that in the miR-19 NC group (45.1±3.9 vs 115.3±8.9, P<0.05). The expression levels of EGFR protein, AKT protein, and mTOR protein in the miR-19 inhibitor group were lower than those in the miR-19 NC group (0.43±0.03 vs 1.02±0.02, 0.52±0.04 vs 1.12±0.05, and 0.63±0.05 vs 1.41±0.06, respectively, all P<0.05).Conclusion　Knockdown of miR-19 expression can inhibit the proliferation, migration and invasion and promote apoptosis in UM cells. The mechanism may be related to the inhibition of EGFR/AKT/mTOR signaling pathway.

参考文献/References:

［1］　DAVANZO J M,BINKLEY E M,BENA J F,SINGH A D.Risk-stratified systemic surveillance in uveal melanoma［J］.Br J Ophthalmol，2019，103(12):1868-1871.
［2］　LORENZO D,PIULATS J M,OCHOA M,ARIAS L,GUTIERREZ C,CATALA J,et al.Clinical predictors of survival in metastatic uveal melanoma［J］.Jpn J Ophthalmol,2019，63(2):197-209.
［3］　ROWCROFT A,LOVEDAY B P,THOMSON B N,BANTING S,KNOWLES B.Systematic review of liver directed therapy for uveal melanoma hepatic metastases［J］.HPB，2020，22(4):497-505.
［4］　YANG C,WANG Y J,HARDY P.Emerging roles of microRNAs and their implications in uveal melanoma［J］.Cell Mol Life Sci，2021，78(2):545-559.
［5］　FALZONE L,ROMANO G L,SALEMI R,BUCOLO C,TOMASELLO B,LUPO G,et al.Prognostic significance of deregulated microRNAs in uveal melanomas［J］.Mol Med Rep，2019，19(4):2599-2610.
［6］　AUGHTON K,KALIRAI H,COUPLAND S E.MicroRNAs and uveal melanoma:understanding the diverse role of these small molecular regulators［J］.Int J Mol Sci，2020，21(16):5648.
［7］　WANG W,ZHANG A,HAO Y,WANG G,JIA Z.The emerging role of miR-19 in glioma［J］.J Cell Mol Med，2018，22(10):4611-4616.
［8］　WU Q,YANG Z,AN Y,HU H,YIN J,ZHANG P.MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1［J］.Cell Death Dis，2014，5(3):e1144-1160.
［9］　KALIKI S,SHIELDS C L.Uveal melanoma:relatively rare but deadly cancer［J］.Eye，2017，31(2):241-257.
［10］　YANG J,MANSON D K,MARR B P,CARVAJAL R D.Treatment of uveal melanoma:where are we now?［J］.Ther Adv Med Oncol，2018，10:1758834018757175.
［11］　CARVAJAL R D,SCHWARTZ G K,TEZEL T,MARR B,FRANCIS J H,NATHAN P D.Metastatic disease from uveal melanoma:treatment options and future prospects［J］.Br J Ophthalmol，2017，101(1):38-44.
［12］　HE B,ZHAO Z,CAI Q,ZHANG Y,ZHANG P,SHI S,et al.miRNA-based biomarkers,therapies,and resistance in Cancer［J］.Int J Biol Sci，2020，16(14):2628.
［13］　PENG J,LIU H,LIU C.MiR-155 promotes uveal melanoma cell proliferation and invasion by regulating NDFIP1 expression［J］.Technol Cancer Res Treat，2017，16(6):1160-1167.
［14］　LING J W,LU P R,ZHANG Y B,JIANG S,ZHANG Z C.miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN［J］.Genet Mol Res，2017，16(3)：325-330.
［15］　XIN X,ZHANG Y,LING F,WANG L,SHENG X H,QIN L,et al.Identification of a nine-miRNA signature for the prognosis of uveal melanoma［J］.Exp Eye Res，2019，180:242-249.
［16］　LI X,TENG C,MA J,FU N,WANG L Y,WEN J,et al.miR-19 family:a promising biomarker and therapeutic target in heart,vessels and neurons［J］.Life Sci，2019，232:116651.
［17］　PENG X,GUAN L,GAO B.miRNA-19 promotes non-small-cell lung cancer cell proliferation via inhibiting CBX7 expression［J］.Onco Targets Ther，2018，11:8865.
［18］　PIETRASZEK-GREMPLEWICZ K,SIMICZYJEW A,DRATKIEWICZ E,PODGORSKA M,STYCZEN I,MATKOWSKI R,et al.Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells［J］.J Cell Mol Med，2019，23(12):8453-8463.
［19］　HORN D,HESSESS J,FREIER K,HOFFMANN J,FREUDLSPERGER C.Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cellcarcinoma［J］. Expert Opin Ther Targets,2015,19(6):795-805.
［20］　曹建忠,李红卫.EGFR突变状态对 NSCLC 脑转移和放疗及靶向治疗疗效影响［J］.中华放射肿瘤学杂志,2016,25(3):296-300.
CAO J Z,LI H W.The effect of brain metastases from NSCLC and treatment targeted plus radiotherapy on EGFR mutations［J］.Chin J Radiat Oncol,2016,25(3):296-300.
［21］　ZHU J,WANG S,CHEN Y.miR-19 targeting of GSK3β mediates sulforaphane suppression of lung cancer stem cells［J］.JNB，2017，44(1):80-91.

相似文献/References:

[1]吴宁玲 吴沂旎 庄曾渊 杨建英 李莹.葛根素对体外培养的视网膜血管内皮细胞增殖的影响[J].眼科新进展,2012,32(7):000.
[2]赵红梅 于靖 盛敏杰 陈轶卉.胰岛素样生长因子结合蛋白-6对 RPE 细胞增殖和迁移的影响[J].眼科新进展,2012,32(3):000.
[3]李明 张永喜 王胜根.葡萄膜黑色素瘤术后自体细胞因子诱导的杀伤细胞治疗效果观察[J].眼科新进展,2012,32(8):000.
[4]张奕霞 杨炜 邱明磊 赵晨.整合素连接激酶对人视网膜色素上皮细胞增殖的影响[J].眼科新进展,2012,32(9):000.
[5]张千帆 刘瑞敏 穆红梅 郭洋 申飞 刘莹.白藜芦醇对视网膜母细胞瘤Y79细胞增殖的影响及其机制[J].眼科新进展,2012,32(11):000.
[6]胡守龙 崔冬梅 于刚 吴倩 曾骏文.胶原相关整合素对人巩膜成纤维细胞增殖和胶原合成的影响[J].眼科新进展,2013,33(6):000.
[7]唐敏 席兴华 唐罗生 岳丽菁.人羊膜匀浆提取液对兔角膜成纤维细胞增殖和TGF-β1mRNA表达的影响[J].眼科新进展,2013,33(11):000.
[8]司艳芳 樊旭 关娟 周历 赵娟. 非转移性黑色素瘤糖蛋白B在增生性玻璃体视网膜病变及视网膜色素上皮细胞中的作用[J].眼科新进展,2014,34(2):131.
[9]徐曼华,李开明,康刚劲.非瑟酮对人晶状体上皮细胞增殖和凋亡的影响[J].眼科新进展,2014,34(8):722.[doi:10.13389/j.cnki.rao.2014.0197]
　XU Man-Hua,Li Kai-Ming,KANG Gang-Jin.Effects of fisetin on proliferation and apoptosis of human lens epithelial cells[J].Recent Advances in Ophthalmology,2014,34(5):722.[doi:10.13389/j.cnki.rao.2014.0197]
[10]鹿晓燕.小鼠胚胎干细胞条件培养基体外促进人角膜内皮细胞增殖的研究[J].眼科新进展,2016,36(3):231.[doi:10.13389/j.cnki.rao.2016.0062]
　LU Xiao-Yan.Proliferation in vitro of human corneal endothelial cells promoted by mouse embryonic stem cell conditioned medium[J].Recent Advances in Ophthalmology,2016,36(5):231.[doi:10.13389/j.cnki.rao.2016.0062]
[11]李娜,曹娟,郁继国,等.miR-26a对葡萄膜黑色素瘤细胞增殖、凋亡、迁移和侵袭的影响及机制研究[J].眼科新进展,2017,37(7):619.[doi:10.13389/j.cnki.rao.2017.0157]
　LI Na,CAO Juan,YU Ji-Guo,et al.Effects of miR-26a on proliferation，apoptosis，migration and invasion of uveal melanoma cell and its mechanism[J].Recent Advances in Ophthalmology,2017,37(5):619.[doi:10.13389/j.cnki.rao.2017.0157]

备注/Memo

备注/Memo:
国家自然科学基金青年基金项目（编号：81800802）
更新日期/Last Update: 2021-05-05